Clinical trial
The Power of Play: Evaluating an Imagination-Inspired Medical Garment for Children
NCT07926984 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Power of Play: Evaluating an Imagination-Inspired Medical Garment for Children
- Lead sponsor
- University of Minnesota
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 1, 2026
- Completion date
- December 31, 2028
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hospitalization in children
Arms
As registered; 2 arms.
-
SuperTee Condition
Two weeks before their child's next hospital visit, Qualtrics surveys will be sent to participants' parent/guardian to capture baseline values of the dependent variables, demographic characteristics, and illness severity information. During the scheduled hospital visit, a member of the study team will be present to administer the SuperTee intervention. The child will receive their SuperTee, will be given time to play with it freely, and then will be guided through an imaginal exercise to encourage them to begin to embody their character. Following the intervention, participants' parents will receive bi-weekly text messages sent via the Mosio platform reminding them to encourage their child to wear their SuperTee. After 6 weeks, a follow-up survey will be sent to capture change on the dependent variables, feedback on the SuperTee (from parent and child), and frequency of use. After an additional 6 weeks, parents will complete a survey version of the dependent variables one final time.
-
SuperTee Waitlist Condition
This arm is the same as the Intervention arm, except they will have a delayed start to receiving the SuperTee intervention.
Primary endpoints
Registered primary outcome measures; 3 primary.
-
Parent-Reported Child Anxiety as assessed using the Spence Preschool Anxiety Scale
Parents will be asked to describe if a series of statements "never," "sometimes," "often," or "always" describe their child. Example items include "my child worries about things" and "my child is scared of the dark." This scale generates a sum score; participants' sum scores from different time points will be compared. Sum scores can range from 0 (low anxiety/better outcome) to 114 (high anxiety/worse outcome).
-
Parent-Reported Child Coping Skills as assessed using the Children's Coping Scale- Revised
Parents will be asked to describe how frequently their child uses a number of both positive and negative coping strategies, with response options comprising "never," "sometimes," or "a lot." All coping strategies are asked about within three different contexts: in general, when saying goodbye, and when the child has to do something that they do not want to do. Positive coping strategies include "spend a lot of time with a good friend" and "ask a teacher for help." Negative example coping strategies, which are reverse-coded, include "keep feelings to self/not show how he/she feels" and "get stomach aches or headaches." A sum-score will also be generated from this scale; participants' sum scores from different time points will be compared. Sum scores can range from 0 (weaker parent-reported coping skills/worse outcome) to 174 (stronger parent-reported coping skills/better outcome).
-
Parent-Reported Child Anxiety as assessed using the Spence Preschool Anxiety Scale
Parents will be asked to describe if a series of statements "never," "sometimes," "often," or "always" describe their child. Example items include "my child worries about things" and "my child is scared of the dark." This scale generates a sum score; participants' sum scores from different time points will be compared. Sum scores can range from 0 (low anxiety/better outcome) to 114 (high anxiety/worse outcome).
Lead sponsor's other trials
University of Minnesota, most recent start first.
+1,211 more trials See the organization page